What's new in pulmonary hypertension clinical research: lessons from the best abstracts at the 2020 American Thoracic Society International Conference.

What's new in pulmonary hypertension clinical research: lessons from the best abstracts at the 2020 American Thoracic Society International Conference.
复制标题

DOI:
10.1177/20458940211040713
复制
发表时间:
2021-07
影响因子:
2.6
通讯作者:
American Thoracic Society Pulmonary Circulation Assembly Early Career Working Group
American Thoracic Society Pulmonary Circulation Assembly Early Career Working Group
中科院分区:
医学4区
文献类型:
--
作者:
Sweatt AJ;Reddy R;Rahaghi FN;Al-Naamani N;American Thoracic Society Pulmonary Circulation Assembly Early Career Working Group

文献摘要

参考文献

相似文献

在这篇会议论文中,我们回顾了2020年美国胸科学会国际会议,题为“肺动脉高压临床研究的新进展:来自最佳摘要的经验教训”。此虚拟小型研讨会于二零二零年十月二十一日举行,以代替因COVID-19疫情而取消的年度ATS国际会议。七个临床研究摘要被选中在会议上介绍,其中包括五个主要主题:(1)规范肺动脉高压的诊断和管理,(2)改善肺动脉高压的风险评估,(3)评估疾病活动的生物标志物,(4)了解肺动脉高压谱中的代谢失调,提高对慢性血栓栓塞性肺动脉高压的认识。围绕这五个主题背景,我们回顾了目前的知识状态,总结了研究摘要,评价其意义和局限性,然后讨论了相关的未来方向在肺动脉高压临床研究。
In this conference paper, we review the 2020 American Thoracic Society International Conference session titled, “What’s New in Pulmonary Hypertension Clinical Research: Lessons from the Best Abstracts”. This virtual mini-symposium took place on 21 October 2020, in lieu of the annual in-person ATS International Conference which was cancelled due to the COVID-19 pandemic. Seven clinical research abstracts were selected for presentation in the session, which encompassed five major themes: (1) standardizing diagnosis and management of pulmonary hypertension, (2) improving risk assessment in pulmonary arterial hypertension, (3) evaluating biomarkers of disease activity, (4) understanding metabolic dysregulation across the spectrum of pulmonary hypertension, and (5) advancing knowledge in chronic thromboembolic pulmonary hypertension. Focusing on these five thematic contexts, we review the current state of knowledge, summarize presented research abstracts, appraise their significance and limitations, and then discuss relevant future directions in pulmonary hypertension clinical research.
DOI: 10.1183/13993003.02095-2018
发表时间: 2019-05-01
影响因子: 24.3
作者:
Brenot, Philippe;Jais, Xavier;Simonneau, Gerald
通讯作者: Simonneau, Gerald
DOI: 10.1016/j.chest.2020.08.2069
发表时间: 2021-01-06
期刊: CHEST
影响因子: 9.6
作者:
Benza, Raymond L.;Kanwar, Manreet K.;Farber, Harrison W.
通讯作者: Farber, Harrison W.
DOI: 10.1016/j.chest.2019.02.004
发表时间: 2019-08-01
期刊: CHEST
影响因子: 9.6
作者:
Benza, Raymond L.;Gomberg-Maitland, Mardi;Frantz, Robert P.
通讯作者: Frantz, Robert P.
DOI: 10.1183/13993003.00889-2017
发表时间: 2017-08-01
影响因子: 24.3
作者:
Boucly, Athenais;Weatherald, Jason;Sitbon, Olivier
通讯作者: Sitbon, Olivier
DOI: 10.1161/jaha.120.018349
发表时间: 2020-11-17
影响因子: 5.4
作者:
Brittain EL;Niswender K;Agrawal V;Chen X;Fan R;Pugh ME;Rice TW;Robbins IM;Song H;Thompson C;Ye F;Yu C;Zhu H;West J;Newman JH;Hemnes AR
通讯作者: Hemnes AR